EQS-News: Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision Marinomed Biotech AG evaluates strategic options for Carragelose portfolio 18.12.2023 / 08:33 CET/CEST The issuer is solely responsible for the…